ATS 2018 International Conference - Mobile

Baseline Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression Predicts Subject Response to Lumacaftor-Ivacaftor Treatment [Board No. P770]

Location: Board no. P770

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Patrick A. Flume

MD
Med Univ of S Carolina;Medical University of South Carolina

Geoffrey S. Gilmartin

MD
Beth Israel Deaconess Medical Ctr;Proteostasis Therapeutics, Inc

Maneet Singh

PhD
Proteostasis Therapeutics, Inc

Felix A. Ratjen

MD, PhD, FRCP(C)
Hospital for Sick Children;The Hospital for Sick Children

Brittany McLaughlin

BA
Proteostasis Therapeutics, Inc

Gregory S. Sawicki

MPH, MD
Boston Children's Hospital

Sheila Wilson

RN
Proteostasis Therapeutics Inc

Calvin Cotton

PhD
Binnacle Biosciences LLC;Case Western Reserve University

Po-Shun Lee

MD
Proteostasis Therapeutics, Inc

Peter E. Bialek

PhD
Proteostasis Therapeutics, Inc

View Abstract

Baseline Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression Predicts Subject Response to Lumacaftor-Ivacaftor Treatment

Parent Sessions

A72 - WHAT'S NEW IN CYSTIC FIBROSIS, BPD AND OTHER CONGENITAL PEDIATRIC LUNG DISEASES...
05-20-2018 9:15 AM - 4:15 PM